insights_auto
Why is EDIT down 9,68%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,96 US$
arrow_downward
-9,68%(-0,21) 1D
16 ნოე, 13:00:55 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,10 US$
High
2,12 US$
Low
1,96 US$
Mkt. cap
302,51 მლნ.
Avg. vol.
2,44 მლნ.
Volume
1,04 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
2,10 US$
High
2,12 US$
Low
1,96 US$
Mkt. cap
302,51 მლნ.
Avg. vol.
2,44 მლნ.
Volume
1,04 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
marketscreener.com
·
31 წუთის წინ
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
32 წუთის წინ
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Benzinga
·
1 საათის წინ
Forget Nvidia — S&P 500's 8,900 Target Puts These ETFs in Play - State Street SPDR S&P 500 ETF Trust (ARC
BigGo Finance
·
3 საათის წინ
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc